339 related articles for article (PubMed ID: 19596662)
1. Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors.
Nagamitsu A; Greish K; Maeda H
Jpn J Clin Oncol; 2009 Nov; 39(11):756-66. PubMed ID: 19596662
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experience of treatment of liver metastasis of renal cell carcinoma treated with SMANCS/Lipiodol therapy].
Umeda S; Ito K; Takahashi E; Kimura F; Sumitomo M; Kaji T; Hayakawa M; Asano T
Hinyokika Kiyo; 2010 Oct; 56(10):543-9. PubMed ID: 21063157
[TBL] [Abstract][Full Text] [Related]
3. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
4. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
5. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
[TBL] [Abstract][Full Text] [Related]
6. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
7. [Arterial infusion chemotherapy with SMANCS].
Nekohashi T; Maruno J; Sanjou A; Toda G
Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025
[No Abstract] [Full Text] [Related]
8. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
Inoue Y; Nakamura H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
[TBL] [Abstract][Full Text] [Related]
9. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
Hirashima N
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma].
Inoue Y; Tomoda K; Oi H; Nakamura H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.
Tsuchiya K; Uchida T; Kobayashi M; Maeda H; Konno T; Yamanaka H
Urology; 2000 Apr; 55(4):495-500. PubMed ID: 10736490
[TBL] [Abstract][Full Text] [Related]
12. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
13. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
[TBL] [Abstract][Full Text] [Related]
14. [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].
Maeda H; Konno T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):773-82. PubMed ID: 2985005
[TBL] [Abstract][Full Text] [Related]
15. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
[TBL] [Abstract][Full Text] [Related]
16. [Our initial experience with SMANCS in TAE for liver cancer].
Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697
[TBL] [Abstract][Full Text] [Related]
17. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K
Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
[TBL] [Abstract][Full Text] [Related]
18. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
Konno T; Maeda H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
[TBL] [Abstract][Full Text] [Related]
19. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
Maeda H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
[TBL] [Abstract][Full Text] [Related]
20. [Arterial infusion of SMANCS for multiple recurrent tumors after hepatic resection].
Takano S; Kono S; Iwai S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():34-8. PubMed ID: 9512685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
